Published in J Am Chem Soc on December 27, 2006
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomedicine (2008) 2.20
Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells. Chem Biol (2007) 1.70
MAGNETIC NANOPARTICLE HYPERTHERMIA IN CANCER TREATMENT. Nano Life (2010) 1.41
Ferritin protein nanocages use ion channels, catalytic sites, and nucleation channels to manage iron/oxygen chemistry. Curr Opin Chem Biol (2011) 1.29
Human ferritin cages for imaging vascular macrophages. Biomaterials (2010) 1.28
Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett (2011) 1.24
RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors. ACS Nano (2013) 1.23
Magnetoferritin nanoparticles for targeting and visualizing tumour tissues. Nat Nanotechnol (2012) 1.20
The ferritin superfamily: Supramolecular templates for materials synthesis. Biochim Biophys Acta (2009) 1.12
Synthesis of a cross-linked branched polymer network in the interior of a protein cage. J Am Chem Soc (2009) 1.09
Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties. Nano Lett (2009) 1.08
Protein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions. ACS Nano (2011) 1.08
Protein nanocapsules containing doxorubicin as a pH-responsive delivery system. Small (2011) 1.07
Re-engineering protein interfaces yields copper-inducible ferritin cage assembly. Nat Chem Biol (2013) 1.06
Radiolabeled nanoparticles for multimodality tumor imaging. Theranostics (2014) 1.01
Intrinsically radiolabeled nanoparticles: an emerging paradigm. Small (2014) 0.99
Protein nanoparticles engineered to sense kinase activity in MRI. J Am Chem Soc (2009) 0.97
RGD-conjugated human ferritin nanoparticles for imaging vascular inflammation and angiogenesis in experimental carotid and aortic disease. Mol Imaging Biol (2012) 0.96
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? Neuroimage (2010) 0.95
Nanoscale assemblies and their biomedical applications. J R Soc Interface (2013) 0.94
Hybrid ferritin nanoparticles as activatable probes for tumor imaging. Angew Chem Int Ed Engl (2011) 0.93
H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection. Proc Natl Acad Sci U S A (2014) 0.90
Aptamer-modified nanodrug delivery systems. ACS Nano (2011) 0.88
Magnetic Resonance Imaging Tracking of Graft Survival in the Infarcted Heart: Iron Oxide Particles Versus Ferritin Overexpression Approach. J Cardiovasc Pharmacol Ther (2014) 0.85
Gene therapy for advanced melanoma: selective targeting and therapeutic nucleic acids. J Drug Deliv (2013) 0.84
Targeted delivery of a photosensitizer to Aggregatibacter actinomycetemcomitans biofilm. Antimicrob Agents Chemother (2010) 0.84
Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles. Int J Nanomedicine (2012) 0.82
Multivalent viral capsids with internal cargo for fibrin imaging. PLoS One (2014) 0.81
Development of virus-like particles for diagnostic and prophylactic biomedical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2015) 0.80
Metalloprotein-based MRI probes. FEBS Lett (2013) 0.79
Size and crystallinity in protein-templated inorganic nanoparticles. Chem Mater (2010) 0.79
Tumor microvasculature targeting with dendrimer-entrapped gold nanoparticles. Soft Matter (2008) 0.78
Ferritins as nanoplatforms for imaging and drug delivery. Expert Opin Drug Deliv (2014) 0.78
Fluorescence resonance energy transfer in ferritin labeled with multiple fluorescent dyes. J Biol Inorg Chem (2007) 0.77
Lumazine Synthase Protein Nanoparticle-Gd(III)-DOTA Conjugate as a T1 contrast agent for high-field MRI. Sci Rep (2015) 0.77
Use of human amelogenin in molecular encapsulation for the design of pH responsive microparticles. BMC Biotechnol (2012) 0.77
X-ray spatial frequency heterodyne imaging of protein-based nanobubble contrast agents. Opt Express (2014) 0.76
Bioinspired nanoscale materials for biomedical and energy applications. J R Soc Interface (2014) 0.76
RGD targeting of human ferritin iron oxide nanoparticles enhances in vivo MRI of vascular inflammation and angiogenesis in experimental carotid disease and abdominal aortic aneurysm. J Magn Reson Imaging (2016) 0.76
Temperature dependence of electron magnetic resonance spectra of iron oxide nanoparticles mineralized in Listeria innocua protein cages. J Appl Phys (2012) 0.76
A histidine aspartate ionic lock gates the iron passage in miniferritins from Mycobacterium smegmatis. J Biol Chem (2014) 0.76
Rational disruption of the oligomerization of the mini-ferritin E. coli DPS through protein-protein interface mutation. Protein Sci (2011) 0.75
X-ray Structure of the Carboplatin-Loaded Apo-Ferritin Nanocage. ACS Med Chem Lett (2017) 0.75
Chaperonin-Dendrimer Conjugates for siRNA Delivery. Adv Sci (Weinh) (2016) 0.75
Targeted delivery system for cancer cells consist of multiple ligands conjugated genetically modified CCMV capsid on doxorubicin GNPs complex. Sci Rep (2016) 0.75
Genetically engineering encapsulin protein cage nanoparticle as a SCC-7 cell targeting optical nanoprobe. Biomater Res (2014) 0.75
Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells. J Vis Exp (2016) 0.75
Enhanced magnetic resonance imaging and staining of cancer cells using ferrimagnetic H-ferritin nanoparticles with increasing core size. Int J Nanomedicine (2015) 0.75
Superparamagnetic Nanoparticles for Atherosclerosis Imaging. Nanomaterials (Basel) (2014) 0.75
High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control (2002) 3.81
Potential environmental impact of a hydrogen economy on the stratosphere. Science (2003) 3.09
Structural and functional characterization of an archaeal clustered regularly interspaced short palindromic repeat (CRISPR)-associated complex for antiviral defense (CASCADE). J Biol Chem (2011) 2.86
Temporal analysis of the honey bee microbiome reveals four novel viruses and seasonal prevalence of known viruses, Nosema, and Crithidia. PLoS One (2011) 2.23
The structure of a thermophilic archaeal virus shows a double-stranded DNA viral capsid type that spans all domains of life. Proc Natl Acad Sci U S A (2004) 2.13
Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California. Cancer Causes Control (2008) 1.93
Comparative lipidomics profiling of human atherosclerotic plaques. Circ Cardiovasc Genet (2011) 1.72
Interferon regulatory factor 3 is a cellular partner of rotavirus NSP1. J Virol (2002) 1.67
Validation of self-reported cancers in the California Teachers Study. Am J Epidemiol (2003) 1.61
Comparative genomic analysis of hyperthermophilic archaeal Fuselloviridae viruses. J Virol (2004) 1.54
Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn Reson Med (2005) 1.48
Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups? Cancer Causes Control (2010) 1.47
Characterization of the archaeal thermophile Sulfolobus turreted icosahedral virus validates an evolutionary link among double-stranded DNA viruses from all domains of life. J Virol (2006) 1.44
Transcriptome analysis of infection of the archaeon Sulfolobus solfataricus with Sulfolobus turreted icosahedral virus. J Virol (2008) 1.37
Particle assembly and ultrastructural features associated with replication of the lytic archaeal virus sulfolobus turreted icosahedral virus. J Virol (2009) 1.36
Regulating self-assembly of spherical oligomers. Nano Lett (2005) 1.34
The effect of body mass index on patient outcomes in a medical ICU. Chest (2005) 1.33
Structural and functional studies of archaeal viruses. J Biol Chem (2009) 1.32
Plant viruses as biotemplates for materials and their use in nanotechnology. Annu Rev Phytopathol (2008) 1.32
Use of cellular CRISPR (clusters of regularly interspaced short palindromic repeats) spacer-based microarrays for detection of viruses in environmental samples. Appl Environ Microbiol (2010) 1.29
Viral capsids as MRI contrast agents. Magn Reson Med (2007) 1.28
Human ferritin cages for imaging vascular macrophages. Biomaterials (2010) 1.28
Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo. Int J Nanomedicine (2007) 1.27
An archaeal antioxidant: characterization of a Dps-like protein from Sulfolobus solfataricus. Proc Natl Acad Sci U S A (2005) 1.24
Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses. PLoS One (2009) 1.23
Melanoma and lymphocyte cell-specific targeting incorporated into a heat shock protein cage architecture. Chem Biol (2006) 1.23
Use of the interior cavity of the P22 capsid for site-specific initiation of atom-transfer radical polymerization with high-density cargo loading. Nat Chem (2012) 1.23
A human ferritin iron oxide nano-composite magnetic resonance contrast agent. Magn Reson Med (2008) 1.23
Multiscale model of CRISPR-induced coevolutionary dynamics: diversification at the interface of Lamarck and Darwin. Evolution (2012) 1.21
A winged-helix protein from Sulfolobus turreted icosahedral virus points toward stabilizing disulfide bonds in the intracellular proteins of a hyperthermophilic virus. Virology (2007) 1.20
Virus movement maintains local virus population diversity. Proc Natl Acad Sci U S A (2007) 1.16
The structure of the CRISPR-associated protein Csa3 provides insight into the regulation of the CRISPR/Cas system. J Mol Biol (2010) 1.16
The role of subunit hinges and molecular "switches" in the control of viral capsid polymorphism. J Struct Biol (2006) 1.14
Targeting and photodynamic killing of a microbial pathogen using protein cage architectures functionalized with a photosensitizer. Langmuir (2007) 1.14
Yeast wall protein 1 of Candida albicans. Microbiology (2005) 1.14
Interaction with capsid protein alters RNA structure and the pathway for in vitro assembly of cowpea chlorotic mottle virus. J Mol Biol (2004) 1.13
A new DNA binding protein highly conserved in diverse crenarchaeal viruses. Virology (2007) 1.12
In vivo assembly of an archaeal virus studied with whole-cell electron cryotomography. Structure (2010) 1.12
The ferritin superfamily: Supramolecular templates for materials synthesis. Biochim Biophys Acta (2009) 1.12
Validating California teachers study self-reports of recent hospitalization: comparison with California hospital discharge data. Am J Epidemiol (2003) 1.11
The structure of the major transition state for folding of an FF domain from experiment and simulation. J Mol Biol (2005) 1.10
Implementation of p22 viral capsids as nanoplatforms. Biomacromolecules (2010) 1.09
Synthesis of a cross-linked branched polymer network in the interior of a protein cage. J Am Chem Soc (2009) 1.09
Nanoreactors by programmed enzyme encapsulation inside the capsid of the bacteriophage P22. ACS Nano (2012) 1.09
Genetically programmed in vivo packaging of protein cargo and its controlled release from bacteriophage P22. Angew Chem Int Ed Engl (2011) 1.08
Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties. Nano Lett (2009) 1.08
Protein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions. ACS Nano (2011) 1.08
Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architecture. Chem Commun (Camb) (2004) 1.07
Hot crenarchaeal viruses reveal deep evolutionary connections. Nat Rev Microbiol (2006) 1.05
Something old, something new, something borrowed; how the thermoacidophilic archaeon Sulfolobus solfataricus responds to oxidative stress. PLoS One (2009) 1.05
Cysteine usage in Sulfolobus spindle-shaped virus 1 and extension to hyperthermophilic viruses in general. Virology (2008) 1.05
Enhanced local symmetry interactions globally stabilize a mutant virus capsid that maintains infectivity and capsid dynamics. J Virol (2006) 1.05
Structure of the DPS-like protein from Sulfolobus solfataricus reveals a bacterioferritin-like dimetal binding site within a DPS-like dodecameric assembly. Biochemistry (2006) 1.04
The architecture and chemical stability of the archaeal Sulfolobus turreted icosahedral virus. J Virol (2010) 1.02
Risk of cancer among rheumatoid arthritis patients in California. Cancer Causes Control (2009) 1.02
A Candida albicans early stage biofilm detachment event in rich medium. BMC Microbiol (2009) 1.01
A radical solution for the biosynthesis of the H-cluster of hydrogenase. FEBS Lett (2005) 1.01
Chemical modification of a viral cage for multivalent presentation. Chem Commun (Camb) (2002) 1.01
Endodontic antimicrobial photodynamic therapy: safety assessment in mammalian cell cultures. J Endod (2009) 1.00
High-density targeting of a viral multifunctional nanoplatform to a pathogenic, biofilm-forming bacterium. Chem Biol (2007) 0.99
Select plant tannins induce IL-2Ralpha up-regulation and augment cell division in gammadelta T cells. J Immunol (2007) 0.99
Adenomyosis and endometriosis in the California Teachers Study. Fertil Steril (2007) 0.99
MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain. Magn Reson Med (2003) 0.98
Atomic structure of the 75 MDa extremophile Sulfolobus turreted icosahedral virus determined by CryoEM and X-ray crystallography. Proc Natl Acad Sci U S A (2013) 0.98
A streptavidin-protein cage Janus particle for polarized targeting and modular functionalization. J Am Chem Soc (2009) 0.98
In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord. Exp Neurol (2004) 0.98
Sulfolobus turreted icosahedral virus c92 protein responsible for the formation of pyramid-like cellular lysis structures. J Virol (2011) 0.98
Differential mRNA expression in circulating gammadelta T lymphocyte subsets defines unique tissue-specific functions. J Leukoc Biol (2003) 0.98
Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza. ACS Nano (2013) 0.97
Clinical implications of the transversus abdominis plane block in pediatric anesthesia. Paediatr Anaesth (2012) 0.97
RGD-conjugated human ferritin nanoparticles for imaging vascular inflammation and angiogenesis in experimental carotid and aortic disease. Mol Imaging Biol (2012) 0.96
Heterologous expression of the modified coat protein of Cowpea chlorotic mottle bromovirus results in the assembly of protein cages with altered architectures and function. J Gen Virol (2004) 0.96
Synergy of NMR, computation, and X-ray crystallography for structural biology. Structure (2009) 0.95
Securinine, a GABAA receptor antagonist, enhances macrophage clearance of phase II C. burnetii: comparison with TLR agonists. J Leukoc Biol (2007) 0.95
Structural studies of E73 from a hyperthermophilic archaeal virus identify the "RH3" domain, an elaborated ribbon-helix-helix motif involved in DNA recognition. Biochemistry (2012) 0.94
Development of a genetic system for the archaeal virus Sulfolobus turreted icosahedral virus (STIV). Virology (2011) 0.94